Combination chemotherapy provides a higher response rate than monodrug therapy for patients with metastatic breast cancer.
No takes yet. Share an insight, caveat, or question.
Supports combination chemotherapy for higher response rates in metastatic breast cancer; leaves open survival benefit and applicability to modern regimens.
Mattsson et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: